These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26141194)

  • 21. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
    Fontanilla CV; Wei X; Zhao L; Johnstone B; Pascuzzi RM; Farlow MR; Du Y
    Neuroscience; 2012 Mar; 205():185-93. PubMed ID: 22206942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome.
    Mills KR
    Brain; 2010 Nov; 133(11):3458-69. PubMed ID: 20959307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities.
    Clark R; Blizzard C; Dickson T
    Neurodegener Dis Manag; 2015 Dec; 5(6):511-25. PubMed ID: 26619150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis.
    Gurney ME; Belton AC; Cashman N; Antel JP
    N Engl J Med; 1984 Oct; 311(15):933-9. PubMed ID: 6472419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
    Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
    Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyotrophic lateral sclerosis: current practice and future treatments.
    Bedlack RS
    Curr Opin Neurol; 2010 Oct; 23(5):524-9. PubMed ID: 20613515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients].
    Iłzecka J; Stelmasiak Z; Dobosz B
    Neurol Neurochir Pol; 2001; 35(6):1035-43. PubMed ID: 11987700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology.
    Kassubek J; Müller HP; Del Tredici K; Brettschneider J; Pinkhardt EH; Lulé D; Böhm S; Braak H; Ludolph AC
    Brain; 2014 Jun; 137(Pt 6):1733-40. PubMed ID: 24736303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteolytic activity in amyotrophic lateral sclerosis IgG preparations.
    Nyormoi O
    Ann Neurol; 1996 Nov; 40(5):701-6. PubMed ID: 8957010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.
    Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ
    Neuropharmacology; 2017 Jan; 112(Pt B):346-364. PubMed ID: 27265569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyotrophic lateral sclerosis in a patient with systemic lupus erythematosus.
    Forns X; Bosch X; Graus F; Navarro M; Font J
    Lupus; 1993 Apr; 2(2):133-4. PubMed ID: 8330035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in protein disulfide isomerase are associated with sporadic amyotrophic lateral sclerosis in the Chinese Han population.
    Yang Q; Guo ZB
    Int J Neurosci; 2016; 126(7):607-11. PubMed ID: 26000911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis in amyotrophic lateral sclerosis--what is the evidence?
    Sathasivam S; Shaw PJ
    Lancet Neurol; 2005 Aug; 4(8):500-9. PubMed ID: 16033692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of Eph receptors in contextual fear conditioning memory formation.
    Dines M; Grinberg S; Vassiliev M; Ram A; Tamir T; Lamprecht R
    Neurobiol Learn Mem; 2015 Oct; 124():62-70. PubMed ID: 26165136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis.
    Ikiz B; Alvarez MJ; Ré DB; Le Verche V; Politi K; Lotti F; Phani S; Pradhan R; Yu C; Croft GF; Jacquier A; Henderson CE; Califano A; Przedborski S
    Cell Rep; 2015 Jul; 12(2):335-45. PubMed ID: 26146077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum microRNAs in sporadic amyotrophic lateral sclerosis.
    Freischmidt A; Müller K; Zondler L; Weydt P; Mayer B; von Arnim CA; Hübers A; Dorst J; Otto M; Holzmann K; Ludolph AC; Danzer KM; Weishaupt JH
    Neurobiol Aging; 2015 Sep; 36(9):2660.e15-20. PubMed ID: 26142125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of EphA4 in Mediating Motor Neuron Death in MND.
    Zhao J; Stevens CH; Boyd AW; Ooi L; Bartlett PF
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1
    Zhao J; Cooper LT; Boyd AW; Bartlett PF
    Sci Rep; 2018 Jul; 8(1):11393. PubMed ID: 30061574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.